Cargando…

A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry

Rapid, high-throughput diagnostic tests are essential to decelerate the spread of the novel coronavirus disease 2019 (COVID-19) pandemic. While RT-PCR tests performed in centralized laboratories remain the gold standard, rapid point-of-care antigen tests might provide faster results. However, they a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feuerherd, M., Sippel, A.-K., Erber, J., Baumbach, J. I., Schmid, R. M., Protzer, U., Voit, F., Spinner, C. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505652/ https://www.ncbi.nlm.nih.gov/pubmed/34635788 http://dx.doi.org/10.1038/s41598-021-99742-7

Ejemplares similares

Seroconversion to HCoV-NL63 in Rhesus Macaques
por: Dijkman, Ronald, et al.
Publicado: (2009)

Understanding Human Coronavirus HCoV-NL63
por: Abdul-Rasool, Sahar, et al.
Publicado: (2010)

Novel polymeric inhibitors of HCoV-NL63
por: Milewska, Aleksandra, et al.
Publicado: (2013)

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2012)

SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
por: Huang, I-Chueh, et al.
Publicado: (2006)

Atypical HCoV-NL63 Infection in an Infant During the SARS-CoV-2 Pandemic
por: Domouzoglou, Eleni M., et al.
Publicado: (2020)

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2
por: Liu, Donglan, et al.
Publicado: (2023)

Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2
por: Nawrath, Philipp, et al.
Publicado: (2022)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Inhibition of HCoV-NL63 infection at early stages of the replication cycle
por: van der Hoek, L., et al.
Publicado: (2006)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
por: Lynch, Sean A., et al.
Publicado: (2021)

Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China
por: Cui, Li-Jin, et al.
Publicado: (2011)

Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses
por: Wondrak, Georg T., et al.
Publicado: (2021)

Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses
por: Wondrak, Georg T., et al.
Publicado: (2021)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study
por: Aldridge, Robert W., et al.
Publicado: (2020)

Corrigendum to ’Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506’ Virus Research (2012) 165/1 [112-117]: Corrigendum
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2022)

HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic
por: Simula, Elena Rita, et al.
Publicado: (2020)

Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro
por: Stone, Nathan E., et al.
Publicado: (2021)

Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2020)

SARS-CoV-2 Is More Efficient than HCoV-NL63 in Infecting a Small Subpopulation of ACE2+ Human Respiratory Epithelial Cells
por: Castillo, Gino, et al.
Publicado: (2023)

Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study
por: Voit, Florian, et al.
Publicado: (2023)

Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) associated with childhood pneumonia in Kilifi, Kenya
por: Otieno, Grieven P., et al.
Publicado: (2020)

GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences
por: Fang, Shuyi, et al.
Publicado: (2020)

From Alpha to Delta—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
por: Morawiec, Emilia, et al.
Publicado: (2022)

BCG vaccination provides protection against IAV but not SARS-CoV-2
por: Kaufmann, Eva, et al.
Publicado: (2022)

Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing
por: Würstle, Silvia, et al.
Publicado: (2021)

Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives
por: Inchingolo, Alessio Danilo, et al.
Publicado: (2022)

Infektionen mit neuem humanen Betacoronavirus 2c EMC/2012 (hCoV-EMC)
por: Uibel, Stefanie, et al.
Publicado: (2014)

Advanced Functions Embedded in the Second Version of Database, Global Evaluation of SARS-CoV-2/hCoV-19 Sequences 2
por: Li, Kailing, et al.
Publicado: (2022)

Origins of HIV, HCoV-HKU1, SFTSV, and MERS-CoV and Beyond
por: Liu, Wenli, et al.
Publicado: (2022)

COVID-Align: accurate online alignment of hCoV-19 genomes using a profile HMM
por: Lemoine, Frédéric, et al.
Publicado: (2020)

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

High prevalence of coronavirus NL63 in SARS-CoV-2 negative COVID-19 suspected patients
por: Sadidi, Roya, et al.
Publicado: (2023)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2
por: Chen, Na, et al.
Publicado: (2022)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
por: Steiner, Sophie, et al.
Publicado: (2020)

Coronavirus humains (HCoV)
por: Vabret, A., et al.
Publicado: (2009)

Human Coronavirus NL63, France
por: Vabret, Astrid, et al.
Publicado: (2005)

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4
por: Jiang, Shibo, et al.
Publicado: (2013)

Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye
por: Al-Sharif, Eman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqf97r3hrqo122u0ort7rvb1ht